Creative Biolabs has expanded its research and development services for edible plant-derived extracellular vesicles (PDEVs), including exosome-like nanovesicles (PELNVs), to support their isolation, purification, characterization, cargo loading, and preclinical evaluation. The company announced the expansion on September 24, 2026, positioning its custom services to aid researchers investigating plant-derived vesicles as biological nanoparticles and experimental delivery systems. The move comes as PDEVs attract increasing attention as alternative nanoscale delivery platforms due to their natural origin, potential scalability, and reported biocompatibility in experimental models. However, their composition and functional properties can vary substantially with plant source, isolation method, and preparation conditions, underscoring the need for systematic research workflows.
Plant-derived EVs have drawn interest because experimental studies have reported favorable biocompatibility and interactions with biological barriers, though these properties depend heavily on vesicle source, composition, preparation, and the experimental model. The vesicles carry endogenous cargos—including small RNAs, specific lipids, and secondary metabolites—that are being investigated for potential biological activity, while the vesicles themselves are explored as delivery vehicles. To address diverse research applications, Creative Biolabs now offers tailored services for EVs from specific plant sources. For skin biology and tissue-repair research, Strawberry-derived EVs are being investigated in oxidative-stress, skin biology, and tissue-repair studies, including examinations of antioxidant-associated cargos and cellular responses relevant to extracellular-matrix biology. For oral delivery and gastrointestinal research, Grapefruit-derived EVs have been investigated for oral-delivery applications, including studies of vesicle stability under gastrointestinal conditions and their potential use as experimental carriers for intestinal delivery. For inflammation, microbial, and immune research, Garlic-derived EVs are being studied for their molecular cargo and potential effects on inflammatory, microbial, and immune-related pathways, generating interest in their use as experimental systems for studying plant-derived bioactive delivery and immunomodulatory mechanisms.
The expanded service platform encompasses technical support throughout the experimental pipeline. The workflow includes isolation and purification of crude plant extracts, multi-dimensional characterization using techniques such as NTA, TEM, and WB, experimental cargo loading (for example, encapsulating small molecules, siRNAs, and peptides), and subsequent in vitro and in vivo biological activity assessments. A scientist at Creative Biolabs stated, "Plant-derived extracellular vesicles are attracting growing research interest because their composition and biological properties can vary substantially across plant sources. A systematic workflow for isolation, characterization, cargo loading, and functional evaluation can help researchers compare these vesicles and investigate their potential in different experimental applications."
This expansion matters for the broader research community because it provides a structured approach to studying plant-derived EVs, which could accelerate investigations into natural delivery systems and bioactive compounds. By offering customized workflows for both mammalian- and plant-derived vesicle systems, Creative Biolabs aims to support the global scientific community in exploring these vesicles for various experimental applications. For more information on plant-derived EV research services, visit https://www.creative-biolabs.com/exosome/. The services are for research use only and not for diagnostic or therapeutic procedures.
